10月8日 - ** Hoth TherapeuticsHOTH.O股价盘前上涨8.5%至1.66美元
** 公司扩大人工智能计划，获得英伟达NVDA.O人工智能企业许可，支持GPU驱动的药物研究
** 该平台将帮助模拟试验、预测毒性和整合患者数据，以加快药物开发 - HOTH
** HOTH 还将利用该技术模拟临床试验并实时监控患者反应
** 推进人工智能是削减成本、改善疗效的更广泛数字战略的一部分 - HOTH
** 截至上次收盘，股价累计上涨 105
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.